Americaine

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of symptoms associated with hemorrhoids, including inflammation, itching, local pain, and soreness.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults, it is recommended that the affected area be cleansed with mild soap and warm water, followed by thorough rinsing. The area should then be gently dried by patting or blotting with toilet tissue or a soft cloth prior to the application of the product. The product may be applied externally to the affected area up to six times daily.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

The use of this product is contraindicated in the following situations:

• Administration via the rectum using fingers, mechanical devices, or applicators is prohibited.

• Dosage should not exceed the recommended amount unless directed by a healthcare professional.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should be aware that certain individuals may develop allergic reactions to the ingredients contained in this formulation. It is imperative to advise patients against the insertion of this product into the rectum using fingers, mechanical devices, or applicators, as this may lead to adverse effects.

Dosage should not exceed the recommended amount unless specifically directed by a healthcare provider. Patients should be instructed to discontinue use and seek medical advice if any of the following occur: the condition worsens or fails to improve within 7 days; any bleeding is observed; or if symptoms such as redness, irritation, swelling, pain, or other adverse reactions develop or intensify.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. There is a potential for certain individuals to develop allergic reactions to the ingredients contained in the formulation.

In clinical practice, it is advised that patients discontinue use and consult a healthcare professional if any of the following occur: the condition worsens or fails to improve within 7 days; any bleeding is observed; or if symptoms such as redness, irritation, swelling, pain, or other adverse effects either occur or intensify. These recommendations are crucial for ensuring patient safety and effective management of their condition.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Americaine (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

Nursing mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the effects on nursing infants are not well studied; therefore, caution is advised.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment and individualized patient assessment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed.

Healthcare providers should instruct patients to discontinue use and consult a doctor if any of the following occur: the condition worsens or does not improve within 7 days, any bleeding is observed, or if symptoms do not improve. Additionally, patients should be made aware that they should seek medical advice if they experience increased redness, irritation, swelling, pain, or any other concerning symptoms.

It is important to inform patients that while using this product, some individuals may develop allergic reactions to its ingredients. Patients should be cautioned against inserting the product into the rectum using fingers, mechanical devices, or applicators. Furthermore, they should not exceed the recommended dosage unless specifically directed by a healthcare professional.

Storage and Handling

The product is supplied in a tube that is tamper evident, ensuring safety and integrity. The tube is sealed for protection; therefore, it should not be used if the foil seal is broken or missing.

Storage conditions require the product to be maintained at room temperature, specifically between 15° and 25°C (59° and 77°F). In the event that the ointment comes into contact with clothing or other fabrics, it is recommended to wash the affected area with warm water only, avoiding the use of bleach.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Americaine, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)